Telemedicine in the Post-Pandemic Era: Market Trends, Clinical Impact, Challenges, and the Road Ahead
Keywords:
Policy, Digital Divide, eSanjeevani, AI in Healthcare, Market Trends, Remote Monitoring, Digital Health, TelemedicineAbstract
Rising throughout COVID-19 and still changing treatment is telemedicine, the remote delivery of healthcare via digital technology.
Reviewing telemedicine's market growth, uses, advantages, obstacles, and case studies would help one to suggest worldwide optimizing tactics.
Methods: Using PubMed, Scopus, WHO, and market-research reports (2020–2025), a narrative review was undertaken. Extracted and synthesized were data on market size, clinical results, and implementation challenges.
Global telemedicine market expected reach USD 364–709 billion by 2031–2034 (CAGR 11–18%), anticipated to be USD 115–135 billion in 2023 Applications of telemedicine include primary care, specialist consultations, remote monitoring, and mental health services. Reduced readmissions, heart failure (mortality risk ↓40%), and diabetes (HbA1c) demonstrate better results in meta-analyses. Technology access gaps, legislative fragmentation, clinical restrictions, and data protection issues comprise some of the obstacles. Case studies: US Medicare exemptions sped up adoption; eSanjeevani from India provided 16 million+ consultations; sub-Saharan Africa pilots encountered connection challenges. Though it needs interpretability frameworks, artificial intelligence integration is ready to automate triage and improve diagnosis.
Downloads
Metrics
References
Almathami, H. K. Y., Win, K. T., & Vlahu-Gjorgievska, E. (2020). Barriers and facilitators that influence telemedicine-based, real-time, online consultation at patients’ homes: Systematic literature review. Journal of Medical Internet Research, 22(2), e16407. https://doi.org/10.2196/16407
American Telemedicine Association. (2020). ATA Telehealth Basics. Retrieved from https://www.americantelemed.org/resource/why-telemedicine/
Bashshur, R. L., Shannon, G. W., Bashshur, N., & Yellowlees, P. M. (2016). The empirical evidence for telemedicine interventions in mental disorders. Telemedicine and e-Health, 22(2), 87–113. https://doi.org/10.1089/tmj.2015.0206
Centers for Medicare & Medicaid Services (CMS). (2020). Medicare Telemedicine Health Care Provider Fact Sheet. Retrieved from https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet
Contreras, C. M., Metzger, G. A., Beane, J. D., Dedhia, P. H., Ejaz, A., & Pawlik, T. M. (2020). Telemedicine: Patient-provider clinical engagement during the COVID-19 pandemic and beyond. Journal of Gastrointestinal Surgery, 24(7), 1692–1697. https://doi.org/10.1007/s11605-020-04623-5
Fact.MR. (2024). Telemedicine market: Global industry analysis and forecast. Retrieved from https://www.factmr.com
Gajarawala, S. N., & Pelkowski, J. N. (2021). Telehealth benefits and barriers. The Journal for Nurse Practitioners, 17(2), 218–221. https://doi.org/10.1016/j.nurpra.2020.09.013
GMI Insights. (2023). Telemedicine market analysis report. Retrieved from https://www.gminsights.com
Grand View Research. (2023). Telemedicine market size, share & trends analysis report. Retrieved from https://www.grandviewresearch.com
Hollander, J. E., & Carr, B. G. (2020). Virtually perfect? Telemedicine for Covid-19. New England Journal of Medicine, 382(18), 1679–1681. https://doi.org/10.1056/NEJMp2003539
Institute of Medicine. (2012). The role of telehealth in an evolving health care environment: Workshop summary. National Academies Press. https://doi.org/10.17226/13466
Keesara, S., Jonas, A., & Schulman, K. (2020). Covid-19 and health care’s digital revolution. New England Journal of Medicine, 382(23), e82. https://doi.org/10.1056/NEJMp2005835
Kruse, C. S., Karem, P., Shifflett, K., Vegi, L., Ravi, K., & Brooks, M. (2018). Evaluating barriers to adopting telemedicine worldwide: A systematic review. Journal of Telemedicine and Telecare, 24(1), 4–12. https://doi.org/10.1177/1357633X16674087
Martinez-Martin, N., et al. (2021). Ethical issues for direct-to-consumer digital psychotherapy apps. Psychiatry, 84(6), 556–566. https://doi.org/10.1080/00332747.2020.1775854
Precedence Research. (2024). Telemedicine market size, trends, and forecast. Retrieved from https://www.precedenceresearch.com
Smith, A. C., Thomas, E., Snoswell, C. L., Haydon, H., Mehrotra, A., Clemensen, J., & Caffery, L. J. (2020). Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). Journal of Telemedicine and Telecare, 26(5), 309–313. https://doi.org/10.1177/1357633X20916567
Organisation for Oceanic Health. (2021). Global telemedicine regulation review: Barriers and opportunities. (Note: Confirm actual publication info if available.)
Wootton, R. (2012). Twenty years of telemedicine in chronic disease management—An evidence synthesis. Journal of Telemedicine and Telecare, 18(4), 211–220. https://doi.org/10.1258/jtt.2012.120219
World Health Organization. (2022). Global strategy on digital health 2020–2025. World Health Organization. Retrieved from https://www.who.int/publications/i/item/9789240020924
World Health Organization. (2020). Telemedicine: Opportunities and developments in Member States: Report on the second global survey on eHealth. World Health Organization. Retrieved from https://apps.who.int/iris/handle/10665/44497
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
